Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yngve Bremnes"'
Publikováno v:
International Journal of Cancer. 121:2506-2511
The associations between endogenous sex hormone levels and breast cancer risk in postmenopausal women are well established. Mammographic density is a strong risk factor for breast cancer, and possibly an intermediate marker. However, the results from
Publikováno v:
International Journal of Cancer. 120:880-884
Postmenopausal hormone therapy (HT) is associated with increased risk of breast cancer. The HTs used in Scandinavia is associated with higher risk estimates than those used in most other countries. Mammographic density is one of the strongest risk fa
Autor:
O. Klepp, Arne Kolstad, Terje Risberg, Harald Holte, Erik Wist, Olav Mella, Tom Wilsgaard, Yngve Bremnes, Barrie R. Cassileth
Publikováno v:
European Journal of Cancer. 40:529-535
This study reports on oncology professionals' knowledge and attitude toward complementary and alternative medicines (CAM), classified according to their primary application as complementary or alternative methods. In June 2002, we conducted a nationa
Publikováno v:
Acta Oncologica. 43:186-189
An open-label, non-randomized, compassionate-use study was carried out to investigate the effects of oral capecitabine at a dose of 1 250 mg/m2 twice daily on days 1 to 14 every 21 days in anthracycline- and taxane-pretreated advanced/metastatic brea
Autor:
Inger T. Gram, Laurie Burdett, Vessela N. Kristensen, Hiroko K. Solvang, Meredith Yeager, Margarethe Biong, Grethe I. Grenaker Alnæs, Ilene Brill, Giske Ursin, Toril Fagerheim, Yngve Bremnes, Fredrik Johansen, Stephen J. Chanock
Publikováno v:
BMC Medical Genomics, Vol 3, Iss 1, p 9 (2010)
BMC Medical Genomics
BMC Medical Genomics
BackgroundIncreased mammographic density is one of the strongest independent risk factors for breast cancer. It is believed that one third of breast cancers are derived from breasts with more than 50% density. Mammographic density is affected by age,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858fa3ddaae758a1a2b6a654638e09cf
https://hdl.handle.net/10037/3046
https://hdl.handle.net/10037/3046
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(1)
Insulin-like growth factor-I (IGF-I) is associated with breast cancer risk among premenopausal women but rarely among postmenopausal women. Recent data from two European studies suggested an increased risk of breast cancer with increasing levels of I
Publikováno v:
Breast cancer research : BCR
Background: Recent cohort studies have suggested an increased risk of breast cancer with long duration of smoking, and with smoking initiation before first birth. Cigarette smoking may have both carcinogenic effects and antiestrogenic effects on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5c0a794e6e73531764b1638c6cb3be
https://hdl.handle.net/10037/1246
https://hdl.handle.net/10037/1246
Publikováno v:
International journal of cancer. 120(4)
Postmenopausal hormone therapy (HT) is associated with increased risk of breast cancer. The HTs used in Scandinavia is associated with higher risk estimates than those used in most other countries. Mammographic density is one of the strongest risk fa
Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study
Autor:
Christian A. Drevon, Marit B. Veierød, Giske Ursin, Inger T. Gram, Anne Stuedal, Janne E. Reseland, Yngve Bremnes
Publikováno v:
Breast Cancer Research
Introduction Obesity has been linked to increased risk of breast cancer in postmenopausal women. Increased peripheral production of estrogens has been regarded as the main cause for this association, but other features of increased body fat mass may
Autor:
Anne Stuedal, Yngve Bremnes, Marit B. Veierød, Herman Adlercreutz, Giske Ursin, Inger T. Gram
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 14(9)
Aims: Certain phytoestrogens, such as lignans, may protect against developing breast cancer. Enterolactone is a lignan metabolite produced by the intestinal flora from dietary precursors such as whole grains, vegetables, and fruits. Enterolactone has